Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

12,958 total articles

Creative Medical Technology Holdings, Inc. Advances Project PHOENIX into Nationwide AI Driven Virtual Data Collection Phase for U.S. Veterans Exposed to Burn Pits and Toxic Hazards

Creative Medical Technology Holdings, Inc. Advances Project PHOENIX into Nationwide AI Driven Virtual Data Collection Phase for U.S. Veterans Exposed to Burn Pits and Toxic Hazards

Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ), a clinical-stage regenerative medicine biotechnology company, announced the advancement of Project PHOENIX—a regulatory-approved, AI-enabled virtual registry and data collection initiative for U.S. veterans exposed to burn pits and toxic hazards. The platform is designed to enroll at least …

Nexxen Launches MCP & Agent-to-Agent AI Integrations to Platform

Nexxen Launches MCP & Agent-to-Agent AI Integrations to Platform

Nexxen announced the launch of new capabilities for its nexAI advertising technology platform, introducing Model Context Protocol (MCP) and Agent-to-Agent (A2A) interoperability. This advancement enables external AI agents to connect with Nexxen's platform, allowing clients to integrate Nexxen's AI-driven data, planning, and activation tools into t…

Chief Patrick Flannelly Highlights KetoAir™ Progress in Supporting the Nevada First Responders Holistic Health Reset Program

Chief Patrick Flannelly Highlights KetoAir™ Progress in Supporting the Nevada First Responders Holistic Health Reset Program

Avalon GloboCare Corp. provided an update on its KetoAir™ breath-based metabolic monitoring technology being utilized in the Nevada POOL/PACT Holistic Health Reset program for first responders. The four-month initiative has seen strong participant engagement and notable improvements in metabolic health metrics, underscoring the potential of KetoAir…

Grayscale Investments Appoints Steve Vanourny as Head of Index

Grayscale Investments Appoints Steve Vanourny as Head of Index

Grayscale Investments announced the appointment of Steve Vanourny as Head of Index, a newly created role designed to expand the firm's index platform across ETFs, private funds, and blockchain-based investment products. Vanourny brings extensive experience from leading roles at ProShares and State Street, positioning Grayscale to leverage growing i…

Open Lending Enters into Merger Agreement to be Acquired by ANV

Open Lending Enters into Merger Agreement to be Acquired by ANV

Open Lending Corporation (NASDAQ: LPRO), a leader in insurance-backed lending solutions, agreed to be acquired by ANV Group Holdings Ltd., a global insurance intermediary platform, in an all-cash tender offer at $3.15 per share. This represents a 78% premium over Open Lending's recent average trading price. The acquisition is expected to close in Q…

Roadzen's VehicleCare Lands $10 Million+ Mandate With Top 10 Indian Insurer, Marking Second Major Win This Quarter

Roadzen's VehicleCare Lands $10 Million+ Mandate With Top 10 Indian Insurer, Marking Second Major Win This Quarter

Roadzen Inc. announced that its VehicleCare platform has secured a $10 million-plus annual revenue mandate from one of India’s top 10 general insurers to manage motor claims repair execution nationwide. Alongside a previously announced similar contract, these deals are expected to contribute over $20 million in combined annual revenue, significantl…

Robin Energy Provides Commercial Update

Robin Energy Provides Commercial Update

Robin Energy Ltd. announced that its two LPG carriers were fully utilized in May 2026 under time charter contracts, generating $713,000 in gross monthly charter revenue. The company secured contracted revenue exceeding $8.4 million for 2026 from its LPG segment, providing strong earnings and cash flow visibility. Additionally, a vessel sale in Apri…

NeOnc Technologies Secures UAE IND Approval for NEO212 Following Successful Phase 1 Completion, Advancing Toward Global Phase 2 Development

NeOnc Technologies Secures UAE IND Approval for NEO212 Following Successful Phase 1 Completion, Advancing Toward Global Phase 2 Development

NeOnc Technologies secured Investigational New Drug (IND) approval from the UAE Department of Health for NEO212, an oral conjugate drug targeting aggressive brain tumors, following successful Phase 1 dose escalation. The clearance supports advancing NEO212 into Phase 2 trials in the UAE, complementing ongoing discussions with the U.S. FDA for poten…

Nimbus Launches Live Red Team Drone Threat Emulation, Deploying Weaponized FPV Systems to Train Forces and Counter-Drone Solutions

Nimbus Launches Live Red Team Drone Threat Emulation, Deploying Weaponized FPV Systems to Train Forces and Counter-Drone Solutions

T3 Defense Inc., through its subsidiary Nimbus Drones Technologies, has introduced a live drone threat emulation service utilizing weaponized FPV drones to train armed forces and test counter-drone solutions. This capability simulates real combat drone attacks, including swarm tactics, to better prepare military and defense clients for evolving unm…

Coherent Announces a CHIPS Letter of Intent for $50 Million to Expand World-Leading Manufacturing Facility for AI Infrastructure

Coherent Announces a CHIPS Letter of Intent for $50 Million to Expand World-Leading Manufacturing Facility for AI Infrastructure

Coherent Corp. has signed a letter of intent to receive up to $50 million under the U.S. CHIPS and Science Act to expand its 6-inch Indium Phosphide semiconductor manufacturing facility in Sherman, Texas. This expansion will boost production capacity quadruple wafer output, create over 1,000 jobs, and support growing demand for optical networking t…

Oncolytics Biotech® Secures New U.S. Patent Protecting Commercial Manufacturing of Pelareorep into 2044

Oncolytics Biotech® Secures New U.S. Patent Protecting Commercial Manufacturing of Pelareorep into 2044

Oncolytics Biotech announced the issuance of a new US patent protecting the commercial manufacturing process of its investigational oncolytic immunotherapy pelareorep, extending patent protection through 2044. A method-of-use patent application is pending, potentially extending protection of pelareorep’s therapeutic use into 2046. Additional patent…

BOS to Participate in the iAccess Alpha Virtual Best Ideas Summer Investment Conference 2026 on June 23–24, 2026

BOS to Participate in the iAccess Alpha Virtual Best Ideas Summer Investment Conference 2026 on June 23–24, 2026

BOS Better Online Solutions Ltd., a NASDAQ-listed integrator of supply chain technologies for aerospace, defense, industrial, and retail sectors, announced its participation in the iAccess Alpha Virtual Best Ideas Summer Investment Conference on June 23-24, 2026. CEO Eyal Cohen and CFO Moshe Zeltzer will deliver a company presentation and engage in…

LPL Financial Welcomes Spectrum Wealth Strategies

LPL Financial Welcomes Spectrum Wealth Strategies

LPL Financial announced that financial advisors from Spectrum Wealth Strategies, managing approximately $1.5 billion in assets, have joined LPL's broker-dealer and RIA platform, moving from MassMutual. This addition strengthens LPL's advisor network and highlights its competitive support model, technology, and autonomy offerings for advisors.

SaverOne Signs Pilot Agreement with RBtec to Expand its RF Sensing Technology into the Security Market

SaverOne Signs Pilot Agreement with RBtec to Expand its RF Sensing Technology into the Security Market

SaverOne 2014 Ltd. has signed a pilot cooperation agreement with RBtec to integrate its advanced RF sensing technology with RBtec's perimeter intrusion detection system for a security sector client. This pilot follows a successful proof of concept and represents a strategic step for SaverOne to expand its technology beyond transportation safety int…

Propanc Biopharma’s CEO Tours European CDMO & Plans for GMP Production of PRP for Phase 1b, FIH Study

Propanc Biopharma’s CEO Tours European CDMO & Plans for GMP Production of PRP for Phase 1b, FIH Study

Propanc Biopharma announced that its CEO toured a European CDMO's GMP facility in preparation for manufacturing its lead product candidate, PRP, for a Phase 1b First-In-Human clinical trial targeting advanced solid tumor cancers. The company outlined plans for preproduction in August 2026, engineering runs in October, and GMP manufacturing starting…